Singapore, Jan 23, 2008: China Medical Technologies announced that it would present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, scheduled to conduct on February 5-7, 2008 at New York.

 

China Medical Technologies’ CEO, Mr Xiaodong Wu; CFO, Mr Sam Tsang; and CTO, Dr Zhong Chen will discuss their corporate strategies, operations and growth opportunities, as well as their published results to date with securities analysts and institutional investors.

 

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in vitro diagnostics products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors.